Transplantation of hematopoietic stem cells from partially matched family donors is a promising therapy for patients who have a hematologic cancer and are at high risk for relapse. The donor T-cell infusions associated with such transplantation can promote post-transplantation immune reconstitution and control residual disease.
CITATION STYLE
Vago, L., Perna, S. K., Zanussi, M., Mazzi, B., Barlassina, C., Stanghellini, M. T. L., … Fleischhauer, K. (2009). Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation. New England Journal of Medicine, 361(5), 478–488. https://doi.org/10.1056/nejmoa0811036
Mendeley helps you to discover research relevant for your work.